StreetInsider.com News Articles

Health Care Select Sect Fd (XLV) call put ratio 4.8 calls to 1 put with a focus on January calls into the annual J.P. Morgan Healthcare Conference

Thu, 08 Jan 2026 11:11:08 -0500

Health Care Select Sect Fd (NYSE: XLV) 30-day option implied volatility is at 15; compared to its 52-week range of 11 to 37. Call put ratio 4.8 calls to 1 put into the annual J.P. Morgan Healthcare Conference.

Health Sector of S&P 500 Hits All Time Highs

Wed, 07 Jan 2026 10:00:49 -0500

Health Sector of S&P 500 Hits All Time Highs

Source: https://www.spglobal.com/spdji/en/indices/equity/sp-500-health-care-sector/#overview
10-year, 5-year, 1-Year all time at 1843.51.
YTD, although a couple trading days, is higher too.

Health Sector of S&P 500 Hits All Time Highs

Wed, 07 Jan 2026 10:00:49 -0500

Health Sector of S&P 500 Hits All Time Highs

Source: https://www.spglobal.com/spdji/en/indices/equity/sp-500-health-care-sector/#overview
10-year, 5-year, 1-Year all time at 1843.51.
YTD, although a couple trading days, is higher too.

Which S&P 500 sectors do you want to own into 2026? BofA answers

Mon, 05 Jan 2026 05:50:22 -0500

(Updated - January 5, 2026 5:50 AM EST)

Investing.com -- In a note to clients this week, analysts at Bank of America highlighted the sectors it model believes investors should own into 2026.

The bank told investors to prioritise Health Care and Real Estate, arguing that both sectors now screen as attractive on valuation and momentum metrics.

BofA writes that its Momentum and Value model “now ranks Health Care as #1 and Real Estate as #3 – and we are overweight both sectors … for investors with a medium term (~12m) outlook.”

The bank adds that it is

Which S&P 500 sectors do you want to own into 2026? BofA answers

Mon, 05 Jan 2026 05:50:22 -0500

(Updated - January 5, 2026 5:50 AM EST)

Investing.com -- In a note to clients this week, analysts at Bank of America highlighted the sectors it model believes investors should own into 2026.

The bank told investors to prioritise Health Care and Real Estate, arguing that both sectors now screen as attractive on valuation and momentum metrics.

BofA writes that its Momentum and Value model “now ranks Health Care as #1 and Real Estate as #3 – and we are overweight both sectors … for investors with a medium term (~12m) outlook.”

The bank adds that it is

Health Care Select Sect Fd (XLV) call put ratio 1 call to 2 puts

Fri, 14 Nov 2025 10:59:00 -0500

Health Care Select Sect Fd (NYSE: XLV) 30-day option implied volatility is at 18; compared to its 52-week range of 12 to 37. Call put ratio 1 call to 2 puts.

Health Care Select Sect Fd (XLV) call put ratio 1 call to 1.4 puts on active option volume of 59K contracts amid sharp rally

Fri, 14 Nov 2025 06:25:08 -0500

Health Care Select Sect Fd (NYSE: XLV) 30-day option implied volatility is at 17; compared to its 52-week range of 12 to 37. Call put ratio 1 call to 1.4 puts on active option volume of 59K contracts amid sharp rally.

Jefferies flags Q3 earnings upside for this pharma giant as key drugs outperform

Tue, 14 Oct 2025 04:00:00 -0500

A major U.S. pharmaceutical group is pacing ahead of expectations this quarter, with analysts pointing to stronger prescription and sales trends that could translate into meaningful earnings upside versus consensus.

Johnson & Johnson’s (NYSE: JNJ) U.S. pharma division, which represents around 89% of its domestic pharma sales base, is now on track for roughly 5% growth, according to brokerage Jefferies, which projected a 2% decline. Bloomberg consensus currently assumes a 2% increase.

If sustained through the quarter, Jefferies estimates that this performance would equate to about 14 cents of earnings per share (EPS) upside, or around 5% relative to its model and

Jefferies flags Q3 earnings upside for this pharma giant as key drugs outperform

Tue, 14 Oct 2025 04:00:00 -0500

If sustained through the quarter, Jefferies estimates that this performance would equate to about 14 cents of earnings per share (EPS) upside, or around 5% relative to its model and

Jefferies flags Q3 earnings upside for this pharma giant as key drugs outperform

Tue, 14 Oct 2025 04:00:00 -0500

If sustained through the quarter, Jefferies estimates that this performance would equate to about 14 cents of earnings per share (EPS) upside, or around 5% relative to its model and

Jefferies flags Q3 earnings upside for this pharma giant as key drugs outperform

Tue, 14 Oct 2025 04:00:00 -0500

If sustained through the quarter, Jefferies estimates that this performance would equate to about 14 cents of earnings per share (EPS) upside, or around 5% relative to its model and

Health Care Select Sect Fd (XLV) options active option volume of 84K contracts

Thu, 02 Oct 2025 04:47:19 -0500

Health Care Select Sect Fd (NYSE: XLV) 30-day option implied volatility is at 17; compared to its 52-week range of 11 to 38 on active option volume of 84K contracts.

Bernstein sees 'a strong buying opportunity' in this U.S. medical stock

Tue, 30 Sep 2025 08:00:00 -0500

The recent selloff in one U.S. medical technology company has created “a strong buying opportunity,” according to Bernstein analysts, pointing to product cycle strength and upside potential in earnings.

The broker sees medical device maker Intuitive Surgical (NASDAQ: ISRG) as well-positioned to recover after a nearly 30% drop from January highs.

“We see more upside to near-term EPS estimates for ISRG than for any other stock in our coverage,” analyst Lee Hambright wrote, adding that one strong quarter of capital sales could be enough to turn momentum.

Bernstein reiterated its Outperform rating and set a $685 price target, implying 56% upside from

Bernstein sees 'a strong buying opportunity' in this U.S. medical stock

Tue, 30 Sep 2025 08:00:00 -0500

The broker sees medical device maker Intuitive Surgical (NASDAQ: ISRG) as well-positioned to recover after a nearly 30% drop from January highs.

Bernstein reiterated its Outperform rating and set a $685 price target, implying 56% upside from

Bernstein sees 'a strong buying opportunity' in this U.S. medical stock

Tue, 30 Sep 2025 08:00:00 -0500

The broker sees medical device maker Intuitive Surgical (NASDAQ: ISRG) as well-positioned to recover after a nearly 30% drop from January highs.

Bernstein reiterated its Outperform rating and set a $685 price target, implying 56% upside from

Bernstein sees 'a strong buying opportunity' in this U.S. medical stock

Tue, 30 Sep 2025 08:00:00 -0500

The broker sees medical device maker Intuitive Surgical (NASDAQ: ISRG) as well-positioned to recover after a nearly 30% drop from January highs.

Bernstein reiterated its Outperform rating and set a $685 price target, implying 56% upside from

Bernstein sees 'a strong buying opportunity' in this U.S. medical stock

Tue, 30 Sep 2025 08:00:00 -0500

The broker sees medical device maker Intuitive Surgical (NASDAQ: ISRG) as well-positioned to recover after a nearly 30% drop from January highs.

Bernstein reiterated its Outperform rating and set a $685 price target, implying 56% upside from

Bernstein sees 'a strong buying opportunity' in this U.S. medical stock

Tue, 30 Sep 2025 08:00:00 -0500

The broker sees medical device maker Intuitive Surgical (NASDAQ: ISRG) as well-positioned to recover after a nearly 30% drop from January highs.

Bernstein reiterated its Outperform rating and set a $685 price target, implying 56% upside from

This MedTech stock is 'a strong buy under $500': Bernstein